Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
---|---|---|---|---|
52014 | NXY-059 ( Disufenton Sodium ) | 168021-79-2 | ≧98.0% | |
NXY-059 ( Disufenton Sodium ) is a disulfonyl derivative of phenyl-tert-butyl nitrone | ||||
232251 | Brepocitinib ( PF-06700841 ) | 1883299-62-4 | ≧98.0% | |
Brepocitinib is a potential first-in-class dual, selective inhibitor of TYK2 and JAK1 | ||||
20460 | Ro5-3335 | 30195-30-3 | ≧98.0% | |
Ro5-3335 is a lipophilic small molecule RUNX1 inhibitor. | ||||
233901 | RRX-001 | 925206-65-1 | ≧98.0% | |
RRx-001 is a highly selective NLRP3 inhibitor with vascular normalization and tumor a | ||||
230401 | Glycerol phenylbutyrate ( HPN-100 ) | 611168-24-2 | ≧98.0% | |
Glycerol phenylbutyrate, also known as HPN-100, is under trials in the treatment of c | ||||
232252 | Brepocitinib Tosylate | 2140301-96-6 | ≧98.0% | |
Brepocitinib ( PF-06700841 ) is an orally available, selective inhibitor of non-recep | ||||
230403 | (R,S)-BI 1015550 | 1423719-27-0 | ≧98.0% | |
BI 1015550 is a novel PDE4 inhibitor showing a preferential enzymatic inhibition of P | ||||
237072 | AZD0095 | 2750001-23-9 | ≧98.0% | |
AZD0095 is a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for Oncology. | ||||
20508 | AZD5991 | 2143061-81-6 | ≧98.0% | |
AZD5991 is a potent and selective Mcl-1 inhibitor for treatment of hematologic cancer | ||||
20511 | PDD4091 | 1373651-41-2 | ≧98.0% | |
PDD4091 is a novel G6PD inhibitor. | ||||
20512 | BDTX-1535 | 2607829-38-7 | ≧98.0% | |
BDTX-1535 is a brain-penetrant and potent MasterKey inhibitor of oncogenic mutations | ||||
20514 | NMS-293 ( NMS-P293 ) | 1606996-12-6 | ≧98.0% | |
NMS-293 is a PARP-1 inhibitor in early clinical development at Nerviano Medical Scien |
Overnight Delivery
Fast & Safe Delivery Worldwide
Safety and Security
Intimate Service
Copyright 2015-2022 武汉永璨生物科技有限公司 版权所有 | 鄂ICP备17005301号-1